Prestige Consumer Healthcare (NYSE:PBH) Updates FY 2026 Earnings Guidance

Prestige Consumer Healthcare (NYSE:PBH) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 4.700-4.820 for the period, compared to the consensus earnings per share estimate of 4.790. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion.

Analyst Upgrades and Downgrades

Several research firms have commented on PBH. Oppenheimer increased their price objective on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. Royal Bank of Canada increased their price target on Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a “sector perform” rating in a research note on Friday, March 21st. DA Davidson lifted their price objective on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Tuesday, April 29th. Finally, Canaccord Genuity Group upped their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, Prestige Consumer Healthcare has an average rating of “Moderate Buy” and a consensus price target of $93.33.

Prestige Consumer Healthcare Price Performance

Shares of Prestige Consumer Healthcare stock opened at $81.25 on Thursday. The stock has a market cap of $4.02 billion, a price-to-earnings ratio of 19.03, a price-to-earnings-growth ratio of 2.69 and a beta of 0.44. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. The stock has a 50 day moving average price of $83.08 and a 200-day moving average price of $81.11. Prestige Consumer Healthcare has a one year low of $62.35 and a one year high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Equities analysts expect that Prestige Consumer Healthcare will post 4.5 EPS for the current year.

Insiders Place Their Bets

In other news, SVP Mary Beth Fritz sold 1,678 shares of the stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the sale, the senior vice president now directly owns 17,157 shares in the company, valued at approximately $1,544,130. This represents a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.60% of the stock is owned by insiders.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.